Literature DB >> 32996839

Human Vaccines & Immunotherapeutics: news.

.   

Abstract

Entities:  

Year:  2020        PMID: 32996839      PMCID: PMC7553672          DOI: 10.1080/21645515.2020.1822656

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  6 in total

1.  Postmarketing Safety of Vaccines Approved by the U.S. Food and Drug Administration : A Cohort Study.

Authors:  Noam Tau; Dafna Yahav; Daniel Shepshelovich
Journal:  Ann Intern Med       Date:  2020-07-28       Impact factor: 25.391

2.  From bad to worse: The representation of the HPV vaccine Facebook.

Authors:  Monique L R Luisi
Journal:  Vaccine       Date:  2020-05-13       Impact factor: 3.641

3.  Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.

Authors:  Pedro M Folegatti; Katie J Ewer; Parvinder K Aley; Brian Angus; Stephan Becker; Sandra Belij-Rammerstorfer; Duncan Bellamy; Sagida Bibi; Mustapha Bittaye; Elizabeth A Clutterbuck; Christina Dold; Saul N Faust; Adam Finn; Amy L Flaxman; Bassam Hallis; Paul Heath; Daniel Jenkin; Rajeka Lazarus; Rebecca Makinson; Angela M Minassian; Katrina M Pollock; Maheshi Ramasamy; Hannah Robinson; Matthew Snape; Richard Tarrant; Merryn Voysey; Catherine Green; Alexander D Douglas; Adrian V S Hill; Teresa Lambe; Sarah C Gilbert; Andrew J Pollard
Journal:  Lancet       Date:  2020-07-20       Impact factor: 79.321

4.  An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.

Authors:  Lisa A Jackson; Evan J Anderson; Nadine G Rouphael; Paul C Roberts; Mamodikoe Makhene; Rhea N Coler; Michele P McCullough; James D Chappell; Mark R Denison; Laura J Stevens; Andrea J Pruijssers; Adrian McDermott; Britta Flach; Nicole A Doria-Rose; Kizzmekia S Corbett; Kaitlyn M Morabito; Sijy O'Dell; Stephen D Schmidt; Phillip A Swanson; Marcelino Padilla; John R Mascola; Kathleen M Neuzil; Hamilton Bennett; Wellington Sun; Etza Peters; Mat Makowski; Jim Albert; Kaitlyn Cross; Wendy Buchanan; Rhonda Pikaart-Tautges; Julie E Ledgerwood; Barney S Graham; John H Beigel
Journal:  N Engl J Med       Date:  2020-07-14       Impact factor: 91.245

5.  An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates.

Authors:  Jesse H Erasmus; Amit P Khandhar; Megan A O'Connor; Alexandra C Walls; Emily A Hemann; Patience Murapa; Jacob Archer; Shanna Leventhal; James T Fuller; Thomas B Lewis; Kevin E Draves; Samantha Randall; Kathryn A Guerriero; Malcolm S Duthie; Darrick Carter; Steven G Reed; David W Hawman; Heinz Feldmann; Michael Gale; David Veesler; Peter Berglund; Deborah Heydenburg Fuller
Journal:  Sci Transl Med       Date:  2020-07-20       Impact factor: 17.956

6.  Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial.

Authors:  Feng-Cai Zhu; Xu-Hua Guan; Yu-Hua Li; Jian-Ying Huang; Tao Jiang; Li-Hua Hou; Jing-Xin Li; Bei-Fang Yang; Ling Wang; Wen-Juan Wang; Shi-Po Wu; Zhao Wang; Xiao-Hong Wu; Jun-Jie Xu; Zhe Zhang; Si-Yue Jia; Bu-Sen Wang; Yi Hu; Jing-Jing Liu; Jun Zhang; Xiao-Ai Qian; Qiong Li; Hong-Xing Pan; Hu-Dachuan Jiang; Peng Deng; Jin-Bo Gou; Xue-Wen Wang; Xing-Huan Wang; Wei Chen
Journal:  Lancet       Date:  2020-07-20       Impact factor: 202.731

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.